Assay developed to detect cathepsin B in blood samples
Scientists have created an assay to detect the protein cathepsin B in blood, a biomarker for a range of diseases.
List view / Grid view
Scientists have created an assay to detect the protein cathepsin B in blood, a biomarker for a range of diseases.
Researchers have shown how different viruses such as HSV-1 and Zika can lead to microcephaly using brain organoids.
Researchers have developed an artificial intelligence to identify the best potential antibody drug from groups of up to a few thousand.
An international collaboration has led to the development of monkey embryos able to grow with injected human stem cells.
Dr Brittany Busse discusses why COVID-19 can influence the onset of diabetes and how this could shape the development of therapeutics.
Novel organoid models of cervical cancer and a healthy human cervix have been developed to study the condition and its progression.
A team has demonstrated in mouse models that a self-assembling nanofibre material could limit the damage caused by cytokines in inflammatory diseases.
Scientists have discovered that manipulating residues enables precision during the antibiotic biosynthesis assembly line.
Delivering Txnip to mice with retinitis pigmentosa was an effective treatment, making this approach a potential gene therapy for the disease.
14 April 2021 | By Fluidigm
Watch our free on-demand webinar to learn more about using Imaging Mass Cytometry™ (IMC™) to measure over 40 protein targets with subcellular resolution.
Induced pluripotent stem cells (iPSC) intestinal organoids have been created to duplicate SARS-CoV-2, enabling drug testing.
Scientists have shown that culturing cells with a modified serum could allow drugs to be screened for toxicity earlier during research.
Researchers have shown that an mRNA delivery system can be used to produce the BDNF protein in rats to protect neurons from ischemia.
Using cryo-electron microscopy, researchers have shown that the Spike (S) protein on cells exposed to the AstraZeneca vaccine is highly similar to the SARS-CoV-2 S protein.
Researchers have created a new single-cell transcriptomics approach that cryopreserves cells, limiting the stress they are put under.